nderstanding the efficacy and process of Schema Therapy in individuals having cluster C personality disorders using a multiple baseline research desig

Not Applicable

Conditions: Health Condition 1: F606- Avoidant personality disorderHealth Condition 2: F607- Dependent personality disorderHealth Condition 3: F605- Obsessive-compulsive personality disorder

Registration Number: CTRI/2022/04/041960

Lead Sponsor: ational Institute of Mental Health and Neurosciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: ot Yet Recruiting

Sex: Not specified

Target Recruitment: 0

Inclusion Criteria

•Patients with a diagnosis of a cluster C PD- AvPD, DPD, OCPD, Mixed cluster C PD according to DSM-V criteria with or without mild to moderate Axis 1

•Patients in the age range of 20-50 years

•Patients who can speak Hindi and English, however, can read in English.

•Patients who are on stable medication or not on any medication before beginning therapy.

•Patients who are willing to commit for approximately 8 months of therapy.

•Patients who are willing to be a part of the baseline period.

Exclusion Criteria

1.Patients having a diagnosis of Personality Disorder (PD) not otherwise specified as well as mixed PD diagnosis.

2.Patients diagnosed with psychotic disorders, severe Axis 1 conditions (CGIS score equal to or more than 4), clinical evidence for neurodevelopmental disorders, or other neurological, neurosurgical or organic conditions that may interfere with engagement in therapy.

3.Patients with substance abuse disorders who are in need of clinical detoxification.

4.Patients who are undergoing regular psychotherapy for PD in the last 3 months.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To examine the efficacy of schema therapy on Personality Disorder severity in patients with cluster C personality disorder using the Levels of Personality Functioning Scale-Brief form 2.0Timepoint: This scale will be administered weekly during the baseline period post which it will be administered before every therapy session till termination

Secondary Outcome Measures

Name	Time	Method
To examine the efficacy of schema therapy on EMS and schema mode change in patients with cluster C personality disorder. <br/ ><br> <br/ ><br>To examine the efficacy of schema therapy on Emotion dysregulation Interpersonal Effectiveness and psychological distress in patients with cluster C personality disorder. <br/ ><br> <br/ ><br>To examine the mediating role of emotion inhibition in the relation between experiential avoidance and cluster PD severity. <br/ ><br> <br/ ><br>To examine the role of early maladaptive schemas and schema mode change in decreasing PD severity. <br/ ><br> <br/ ><br>To understand the clients experiences of helpful and unhelpful aspects of schema therapy. <br/ ><br>Timepoint: Baseline <br/ ><br>Exploration phase <br/ ><br>Treatment phase <br/ ><br>Post treatment completion